Lisa Olson
Chief Executive Officer en Enthera Srl .
Fortuna: 26 760 $ al 31/03/2024
Perfil
Lisa M.
Olson is currently the Chief Executive Officer at Enthera Srl, Director at Lassen Therapeutics 1, Inc., and an Assistant Professor at Washington University School of Law.
Previously, she was a Director at Enthera.
Srl, Vice President-Immunology Discovery at AbbVie Bioresearch Center, Inc., and the Chief Scientific Officer & Head-Research at Magenta Therapeutics, Inc. She received her undergraduate degree from Iowa State University and her doctorate from the University of Illinois At Urbana–Champaign.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2023 | 892 ( 0.00% ) | 26 760 $ | 31/03/2024 |
Cargos activos de Lisa Olson
| Empresas | Cargo | Inicio |
|---|---|---|
| Washington University School of Law | Corporate Officer/Principal | - |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Director/Board Member | 07/10/2021 |
Enthera Srl
 Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Chief Executive Officer | 23/01/2024 |
Antiguos cargos conocidos de Lisa Olson.
| Empresas | Cargo | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 15/05/2023 |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Director/Board Member | - |
| AbbVie Bioresearch Center, Inc. | Corporate Officer/Principal | - |
Formación de Lisa Olson.
| Iowa State University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
| AbbVie Bioresearch Center, Inc. | |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Health Technology |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Olson
